Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited announced that its Cefotaxime Sodium for Injection has passed the quality and efficacy consistency evaluation by the China National Medical Products Administration. This approval reinforces the company’s leadership in the anti-infective field and is expected to enhance its value creation for shareholders through continued research and development of new products.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. It focuses on the development and production of generic drugs, with a significant market presence in anti-infective medications.
YTD Price Performance: -9.81%
Average Trading Volume: 9,785
Technical Sentiment Signal: Sell
Current Market Cap: $2.93B
For a thorough assessment of 3933 stock, go to TipRanks’ Stock Analysis page.